Drug Shortage Report for TARO-PREGABALIN
Report ID | 208108 |
Drug Identification Number | 02392844 |
Brand name | TARO-PREGABALIN |
Common or Proper name | PREGABALIN |
Company Name | SUN PHARMA CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | PREGABALIN |
Strength(s) | 150MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL ORAL |
Packaging size | 500 |
ATC code | N02BF |
ATC description | |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2023-11-01 |
Actual start date | |
Estimated end date | 2023-11-17 |
Actual end date | 2023-01-26 |
Shortage status | Avoided shortage |
Updated date | 2024-01-05 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 126 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2024-01-05 | French | Compare |
v4 | 2024-01-05 | English | Compare |
v3 | 2023-11-02 | English | Compare |
v2 | 2023-10-25 | French | Compare |
v1 | 2023-10-25 | English | Compare |
Showing 1 to 5 of 5